MR Watts, PC Taylor, V Sintchenko… - Clinical Infectious …, 2011 - cid.oxfordjournals.org ... Resistant Mycobacterium bovisBacillus Calmette-Guérin disease: implications for management of Bacillus Calmette-Guérin ... American Thoracic Society / Centres for Disease Control and Prevention / Infectious Diseases Society of America: treatment of tuberculosis. ... Cited by 1 - Related articles - All 4 versions
MA Chambers, F Rogers… - … of the Royal …, 2011 - rspb.royalsocietypublishing.org ...Bacillus Calmette-Guérin (BCG) is an attenuated strain of M. bovis, which is widely used around the world as a vaccine against human TB caused by Mycobacterium tuberculosis. BCG protects against severe childhood forms ... Cited by 5 - Related articles - All 5 versions
[HTML] from hindawi.comS Nunzia, C Alessia, G Manuela… - Clinical and …, 2011 - hindawi.com In order to analyze dendritic cells (DCs) activation following infection with different mycobacterial strains, we studied the expression profiles of 165 genes of human monocyte-derived DCs infected with H37Rv, a virulent Mycobacterium tuberculosis (MTB) laboratory strain, CMT97, a ... Related articles - Cached - All 5 versions
X Yang, L Bao… - Acta Biochimica et Biophysica …, 2011 - abbs.oxfordjournals.org Since Mycobacterium bovis bacillus Calmette−Guerin strain (BCG) fails to protect adults from pulmonary tuberculosis (TB), there is an urgent need for developing a new vaccine. In this study, we constructed a novel recombinant BCG strain (rBCG) expressing human ... Related articles - All 3 versions
Y Ozeki, Y Hirayama, T Takii, S Yamamoto… - Vaccine, 2011 - Elsevier ... Abstract. Mycobacterium bovisbacillus Calmette-Guérin (BCG) is the most often used vaccine worldwide and sole vaccine against tuberculosis. BCG is protective against severe form of childhood tuberculosis but less or not protective to adult pulmonary tuberculosis. ...